Beijing Winsunny Pharmceutical Co.,Ltd.   Report issue

For profit Phase 1
Founded: Beijing China (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2018
NCT03504475
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Beijing Winsunny Pharmceutical Co.,Ltd.